Statistics for Evaluation of LMP-420: A Novel, Nontoxic Drug with Anti-Inflammatory Properties and Therapeutic Potential for CLL

Total visits

views
Evaluation of LMP-420: A Novel, Nontoxic Drug with Anti-Inflammatory Properties and Therapeutic Potential for CLL 713

Total visits per month

views
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 1

File Visits

views
Mowery_duke_0066D_10723.pdf 531

Top country views

views
United States 179
China 160
Germany 43
United Kingdom 34
France 21
Russia 21
Canada 13
South Korea 10
India 6
Seychelles 5
Austria 4
Switzerland 4
Iran 4
Netherlands 4
Portugal 4
Australia 3
Spain 2
Mauritius 2
Puerto Rico 2
Turkey 2
Venezuela 2
Belgium 1
Brazil 1
Côte d’Ivoire 1
Colombia 1
Czechia 1
European Union 1
Hong Kong SAR China 1
Hungary 1
Ireland 1
Jordan 1
Malaysia 1
Norway 1
Singapore 1

Top city views

views
San Antonio 58
Beijing 22
Alexandria 21
Durham 21
Hebei 12
Yucaipa 12
Göttingen 10
Moscow 8
Omemee 8
Kiez 7
Seoul 6
Chicago 5
La Jolla 5
Shanghai 5
Tianjin 5
Woodbridge 5
Guilford 4
Lisbon 4
San Diego 4
San Francisco 4
Shenzhen 4
Waynesboro 4
Jinan 3
Magdeburg 3
Middletown 3
Mountain View 3
Raleigh 3
Stanford 3
Tokyo 3
Caracas 2
Chaoyang 2
Edmonton 2
Gainesville 2
Montreal 2
Mumbai 2
New York 2
Pirooz 2
Saint Petersburg 2
Tolyatti 2
Tottori 2
Winston Salem 2
Abidjan 1
Ampang 1
Apeldoorn 1
Apex 1
Augusta 1
Baltimore 1
Bedford 1
Bello 1
Braunschweig 1
Brussels 1
Cary 1
Central District 1
Changi 1
Clayton 1
Dublin 1
Düsseldorf 1
East Elmhurst 1
Ebbw Vale 1
Englishtown 1
Guizhou 1
Gurgaon 1
Hyderabad 1
Hösting 1
Kansas City 1
Lake Forest 1
Linz 1
Mebane 1
Munich 1
Napa 1
Newark 1
Nyon 1
Ottawa 1
Overland Park 1
Paris 1
Pittsburgh 1
Poway 1
Richmond 1
Rochester 1
Saint Louis 1
Sapporo 1
Seattle 1
Stamford 1
Suzhou 1
Sydney 1
Tabriz 1
Tampa 1
Tehran 1
Trubschachen 1
Tucson 1
University Park 1
Vacoas 1
Vienna 1
Washington 1
Wädenswil 1
Yokohama 1
Yulee 1
Zürich 1